Lokon Pharma
Phase 1/2Lokon Pharma is a biotech company in the immune oncology space with immunostimulatory gene therapy as the main focus.
Founded
2016
Focus
Viral Technology
About
Lokon Pharma is a biotech company in the immune oncology space with immunostimulatory gene therapy as the main focus.
Funding History
2Total raised: $17.5M
Series A$15MIndustrifondenSep 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2016
LocationStockholm, Sweden
StagePhase 1/2
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile